Overnight Digest- Stocks to look out for on June 9

DSIJ Intelligence / 08 Jun 2017

Overnight Digest- Stocks to look out for on June 9

The stocks which are expected to witness significant movement on June 9 are Zee Entertainment Enterprises, IOCL/HPCL, SpiceJet, BSE and Bodhtree Consulting.

Zee Entertainment Enterprises: The company announced on June 8 that it will be acquiring the balance 49 per cent equity stake in its subsidiary India Webportal for USD 30.7 million (Rs 197.47 crore). The share price of the company will remain in the limelight on Friday. 

IOCL/HPCL: The government announced on Thursday that the petrol and diesel prices will be revised on a daily basis from June 16. The share prices of the state-owned oil companies will be in focus on June 9.

SpiceJet: The airlines major SpiceJet announced the launch of eight new direct flights and one connecting flight effective from July. The share price of the company will remain in the limelight on Friday.

BSE: Bombay Stock Exchange launched new framework ‘S+ Framework’ for enhanced monitoring of BSE main board companies. The share price of the company will be watched on June 9.

Bodhtree Consulting Limited: The company announced on Thursday that it has entered into strategic partnership with Infosys as an application service provider (ASP) for their GST filings. The share price of company will be remain in the limelight on Friday.

If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.